Keyphrases
Confidence Interval
81%
Breast Cancer
53%
Tumor
51%
Overall Survival
40%
Inhibitory Effect
39%
Prostate Cancer
35%
Odds Ratio
32%
Vitamin E
32%
Localized Prostate Cancer
30%
Breast Cancer Survivors
30%
Phorbol 12-myristate 13-acetate
29%
Breast Cancer Risk
29%
Black Women
29%
Hazard Ratio
27%
New Jersey
26%
Framingham Offspring Study
25%
Ultraviolet-B (UV-B)
24%
Atorvastatin
24%
Celecoxib
24%
Clinical Trials
23%
Androgen Deprivation Therapy
22%
Caffeine
22%
Immunodeficient Mice
20%
Skin Carcinogenesis
20%
Body Mass Index
20%
In Cancer
19%
Running Wheel Exercise
19%
Comorbidity
18%
United States
18%
Prostate-specific Antigen
18%
Metformin
17%
Cancer Risk
17%
Conservative Management
17%
LNCaP
16%
Single nucleotide Polymorphism
16%
Advanced Malignancies
16%
Cancer Genetics Risk Assessment
16%
Predictive Biomarker
16%
SKH-1 Hairless Mice
15%
Prostate
15%
Breast Cancer Mortality
15%
Adiposity
15%
High Risk
14%
Gene Expression
14%
Androgen-independent
14%
Prostate Tumor
14%
African American Women
14%
Breast Cancer Diagnosis
14%
Surveillance Epidemiology
14%
Voluntary Exercise
14%
Medicine and Dentistry
Breast Cancer
100%
Prostate Cancer
60%
Neoplasm
54%
Malignant Neoplasm
46%
Overall Survival
33%
Diseases
30%
Radiation Therapy
29%
Cancer
22%
Cancer Diagnosis
22%
Androgen Deprivation Therapy
21%
Breast Tumor
18%
Cancer Risk
18%
Prostate Specific Antigen
18%
Odds Ratio
17%
Carcinogenesis
17%
Hazard Ratio
17%
Comorbidity
17%
Cancer Therapy
16%
Body Mass Index
16%
Genetic Risk
16%
Conservative Treatment
16%
Diabetes
13%
Lung Cancer
12%
Randomized Controlled Trial
12%
DNA Microarray
12%
Acute Myeloid Leukemia
12%
Therapy Delay
12%
Abdominal Cancer
12%
Cancer Genetics
12%
Offspring
12%
Cancer Specific Survival
11%
Obesity
11%
Estrogen Receptor
11%
Gene Expression
11%
Clinical Trial
11%
Colorectal Carcinoma
11%
Arm
11%
Logistic Regression Analysis
10%
Progression Free Survival
10%
National Health and Nutrition Examination Survey
10%
Prostatectomy
10%
Adipocytokine
10%
Programmed Cell Death
10%
Surveillance, Epidemiology, and End Results
9%
Mediator
9%
Medicare
9%
Surgery
9%
Prognostication
8%
Race Difference
8%
Metastatic Carcinoma
8%